MaxQ AI, a clinical-stage medical device company developing an AI-based medical imaging platform, filed on Thursday with the SEC to raise up to $8 million in an initial public offering.
The Tel Aviv, Israel-based company was founded in 2013 and plans to list on the Nasdaq under the symbol MQAI. MaxQ AI filed confidentially on February 13, 2018. ViewTrade is the sole bookrunner on the deal. No pricing terms were disclosed.
